» Articles » PMID: 33235718

Neuroprotective Effect of Mulmina™ Against Chemotherapy-induced Cognitive Decline in Normal Mice

Overview
Journal Biomed Rep
Specialty Biochemistry
Date 2020 Nov 25
PMID 33235718
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of the present study was to evaluate a marketed formulation against chemotherapy-induced cognitive dysfunction. The formulation, Mulmina™, contains natural compounds which are known to help in improving function as well as in preventing cognitive decline. All of the phytoconstituents in the formulation have been tested individually but this is the first study where such a formulation has been evaluated against chemotherapy-induced cognitive decline (CICD) in a mouse model. CICD was induced by cyclophosphamide (50 mg/kg), methotrexate (5 mg/kg), and 5-fluorouracil (5 mg/kg) (CMF), administered intraperitonially. CMF was administered in three cycles, with one injection per week for three weeks. The decline in cognition of the mice was evaluated by a test of locomotor activity (Open Field Test) followed by a test for spatial memory (Morris Water Maze). Biochemical parameters evaluated include brain cytokine levels and BDNF levels via ELISA. Hematological counts were also performed to evaluate any changes in blood profile using a veterinary blood cell counter. Levels of oxidative stress markers with respect to catalase activity and lipid peroxidation were also evaluated in the brain using UV-spectrophotometric analysis. Mulmina™ was able to show significant improvement in cognitive function post chemotherapy when compared to the untreated animals. Apart from improvement in spatial memory, there was also an improvement in biochemical parameters. The particular combination of phytochemicals in Mulmina™ proved themselves successful in alleviating the CICD in this preliminary study and pave a path for future studies which can establish the solid grounds with respect to molecular and pharmacological basis for the mechanism of action of Mulmina™.

Citing Articles

Neurotoxicity of the antineoplastic drugs: "Doxorubicin" as an example.

Fouad G, Rizk M J Mol Histol. 2024; 55(6):1023-1050.

PMID: 39352546 DOI: 10.1007/s10735-024-10247-9.


Neuroprotective effect of herbal extracts inhibiting soluble epoxide hydrolase (sEH) and cyclooxygenase (COX) against chemotherapy-induced cognitive impairment in mice.

Kulkarni R, Mehta R, Goswami S, Hammock B, Morisseau C, Hwang S Biochem Biophys Res Commun. 2023; 667:64-72.

PMID: 37209564 PMC: 10849156. DOI: 10.1016/j.bbrc.2023.05.008.


Neuroprotective effect of Mulmina Mango against chemotherapy-induced cognitive decline in mouse model of mammary carcinoma.

John J, Kinra M, Ranadive N, Keni R, Nayak P, Jagdale R Sci Rep. 2022; 12(1):3072.

PMID: 35197512 PMC: 8866531. DOI: 10.1038/s41598-022-06862-9.


Chemotherapy-Induced Cognitive Impairment and Hippocampal Neurogenesis: A Review of Physiological Mechanisms and Interventions.

Sekeres M, Bradley-Garcia M, Martinez-Canabal A, Winocur G Int J Mol Sci. 2021; 22(23).

PMID: 34884513 PMC: 8657487. DOI: 10.3390/ijms222312697.


Chemotherapy-induced cognitive impairment: focus on the intersection of oxidative stress and TNFα.

Rummel N, Chaiswing L, Bondada S, St Clair D, Butterfield D Cell Mol Life Sci. 2021; 78(19-20):6533-6540.

PMID: 34424346 PMC: 10561769. DOI: 10.1007/s00018-021-03925-4.

References
1.
Staat K, Segatore M . The phenomenon of chemo brain. Clin J Oncol Nurs. 2005; 9(6):713-21. DOI: 10.1188/05.CJON.713-721. View

2.
Briones T, Woods J . Chemotherapy-induced cognitive impairment is associated with decreases in cell proliferation and histone modifications. BMC Neurosci. 2011; 12:124. PMC: 3252305. DOI: 10.1186/1471-2202-12-124. View

3.
Jim H, Phillips K, Chait S, Faul L, Popa M, Lee Y . Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy. J Clin Oncol. 2012; 30(29):3578-87. PMC: 3462044. DOI: 10.1200/JCO.2011.39.5640. View

4.
Wu A, Ying Z, Gomez-Pinilla F . Dietary curcumin counteracts the outcome of traumatic brain injury on oxidative stress, synaptic plasticity, and cognition. Exp Neurol. 2005; 197(2):309-17. DOI: 10.1016/j.expneurol.2005.09.004. View

5.
Feng S, Wang Z, Yuan Y, Sun H, Chen N, Zhang Y . Mangiferin: A multipotent natural product preventing neurodegeneration in Alzheimer's and Parkinson's disease models. Pharmacol Res. 2019; 146:104336. DOI: 10.1016/j.phrs.2019.104336. View